Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPA
Status:
Recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to identify the optimal maintenance therapy for granulomatosis with
polyangiitis (GPA) by comparing the MTX (standard regimen) with Tofacitinib in terms of
efficacy, i.e. in preventing relapses.